ABBOTT INDIA LIMITED HomeValidate
General information about company
Name of The Company | Abbott India Limited | ||
BSE Scrip Code | 500488 | ||
NSE Symbol | |||
MSE Symbol | |||
Date of Start of Financial Year | 01 | 04 | 2021 |
Date of End of Financial Year | 31 | 03 | 2022 |
Reporting Period | First half yearly | ||
Date of Start of Reporting Period | 01 | 04 | 2021 |
Date of End of Reporting Period | 30 | 09 | 2021 |
Level of rounding used in financial results | Crores | ||
Whether the company has entered into any | |||
Related Party transaction during the selected | Yes | ||
half year for which it wants to submit | |||
disclosure? |
Home | Validate | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related party transactions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A. Details of related party | B. Details of related party transactions | C. Outstanding balances | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Remuneration | Receivables | Payables | Loans and advances given | Loans and advances taken | Deposits placed | Deposits taken | Guarantees or collateral given | Guarantees or collateral taken | Investment in equity | Provision for doubtful debt | Note | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sr | Name of the related party | Categories of related parties | description of relationship | PAN of related party | CIN of related party | Purchase of goods and | Sale of goods and | Purchase of fixed assets | Sale of fixed assets | Rendering of services | Receiving of services | Leases | Loans and advances | Loans and advances | Loans and advances | Loans and advances | Deposits placed | Deposits taken | Transfer of research & | Transfers under lease | Equity investment | Impairment in equity | Expense for bad or | Guarantees or collateral | Guarantees or collateral | Interest income | Interest paid | Dividend income | Dividend paid | Management contracts including for | Settlement of liabilities by entity on | Short term employee | Post employment | Other long-term | Termination benefits | Share based payments | Others | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | Secured | Un Secured | ||||||||||
services | services | given | taken | given that are repaid | taken that are repaid | development | agreement | investment | doubtful debts | given | taken | deputation of employees | behalf of related party | benefits | benefits | benefits | |||||||||||||||||||||||||||||||||||||||||||||||||||
Add | Delete | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 | Abbott Capital India Ltd., UK | Promoters | Promoters | ZZZZZ9999Z | 294.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | British Colloids Ltd., U.K. | Promoters | Promoters | ZZZZZ9999Z | 40.43 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Abbott Healthcare Products Ltd., U.K | Promoters | Promoters | ZZZZZ9999Z | 102.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Abbott Healthcare Private Ltd, India | Other related party | Fellow subsidiary | AAACK3935D | U24200MH1997PTC104834 | 45.65 | 41.14 | 27.12 | 14.18 | 16.61 | 19.88 | 126.51 | 14.80 | 0.45 | 3.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Abbott Products Operations AG. Switzerland | Other related party | Fellow subsidiary | ZZZZZ9999Z | 142.28 | 1.19 | 0.51 | 79.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Alere Medical Pvt. Ltd., India | Other related party | Fellow subsidiary | AABCS2425B | U74899DL1995PTC069456 | 0.18 | 0.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Abbott International LLC, USA | Other related party | Fellow subsidiary | ZZZZZ9999Z | 0.30 | 0.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Abbott Laboratories, Ireland | Other related party | Fellow subsidiary | ZZZZZ9999Z | 0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Abbott Laboratories (Singapore) Pte, Singapore | Other related party | Fellow subsidiary | ZZZZZ9999Z | 0.52 | 0.54 | 0.10 | 0.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Abbott Laboratories S.A., Dubai | Other related party | Fellow subsidiary | ZZZZZ9999Z | 0.52 | 0.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | St Jude Medical India Private Limited, India | Other related party | Fellow subsidiary | AAICS9821J | U33110TG2005PTC046028 | 0.62 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Munir Shaikh | Key management personnel of | Non-Executive Director | CVEPS1383P | 0.06 | 4.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
entity or parent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Anisha Motwani | Key management personnel of | Independent Director | AAAPM1617P | 0.07 | 5.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
entity or parent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Sudarshan Jain | Key management personnel of | Independent Director | AAAPJ8141R | 0.07 | 6.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
entity or parent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Shalini Kamath | Key management personnel of | Independent Director | AAQPK0502M | 0.07 | 7.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
entity or parent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Anil Joseph | Key management personnel of | Managing Director | AGJPJ8827H | 1.53 | 11.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
entity or parent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Rajiv Sonalker | Key management personnel of | Whole-time Director | AGTPS1950J | 1.08 | 10.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
entity or parent |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Abbott India Limited published this content on 13 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 December 2021 10:37:07 UTC.
